FDA Approves Omalizumab to Reduce Food-Based Allergic Reactions in Adult and Pediatric Patients
This marks omalizumab’s fourth FDA-approved indication for allergic and inflammatory conditions, such as severe persistent allergic asthma, with its initial approval being in 2003.
Investigators Determine Best ACT-S is a Valid Questionnaire for Asthma Control in Children, Adolescents
The study authors note that the Best ACT-S questionnaire complements the Best ACT-P questionnaire, a previously developed questionnaire that assesses preschool-aged patients with asthma.
Individuals With Inflammatory Disease Did Not Have Higher Risk of VTE Following COVID-19 Infection
The study results also indicate no significant difference of venous thromboembolism risk between individuals with immune-mediated inflammatory diseases and individuals without.
IVIg Treatment Significantly Reduces Risk of Severe Infections in Patients With Multiple Myeloma
IVIg treatment may need to be given proactively both throughout the duration of anti-BCMA bispecific antibody therapy and afterward.
Better Sleep Consolidation, Absence of Obstructive Sleep Apnea Are Associated With Better Cognition Over 5 Years of Follow-Up
Further research is necessary in order to investigate whether poor sleep can be a potential risk factor for dementia.
2 Commerce Drive Cranbury, NJ 08512